Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Merck Settles Vioxx Lawsuit

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Pharmaceutical powerhouse Merck (NYSE: MRK  ) has agreed to settle a class action lawsuit filed in Missouri by Vioxx customers, the company announced yesterday.

Those who filed the lawsuit had purchased Merck's prescription pain reliever Vioxx before it was pulled from the market in 2004 because of concerns about increased risk of heart attack and stroke, but claimed no physical injury. It was filed under the Missouri Merchandising Practices Act. Merck has agreed to pay "to resolve all validated claims submitted by class members," the company said, as well as pay attorneys' fees and administrative costs.

When it was filed in 2004, the class action sought $220 million in total damages for Missouri residents who had purchased Vioxx.

The issue has been previously disclosed by Merck, and a charge was booked in the third quarter of this year to account for the potential amount of the settlement. Merck's general counsel, Bruce Kuhlik, said in a company press release that the agreement is "in the best interest of the company and its shareholders. It reduces the uncertainty of litigation and ongoing defense costs."

The agreement has to be approved by the court before it is final.

John Divine has no positions in the stocks mentioned above. You can follow him on Twitter @divinebizkid and on Motley Fool CAPS @TMFDivine.

The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2092407, ~/Articles/ArticleHandler.aspx, 10/23/2016 4:19:16 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:00 PM
MRK $61.20 Down -0.72 -1.16%
Merck and Co. CAPS Rating: ****